IBM vs MNPR · P/E 25, rev $17.16B vs $431.4M cap
International Business Machines (IBM) versus Monopar Therapeutics Inc (MNPR) — a side-by-side from cached financials, not a winner call.
International Business Machines (IBM) is a information technology services company listed on US. It is led by Arvind Krishna.
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
Latest reported IBM revenue for 2026-06-30 was $17.16B. Net income was $2.17B. Revenue was up 7.8% from 2026-03-31 to 2026-06-30. IBM currently screens at market cap $267.72B and trailing P/E 25.2.
Latest reported MNPR revenue for 2026-06-30 was $0. Net income was -$9.2M. MNPR currently screens at market cap $431.4M.
IBM currently screens at market cap $267.72B and trailing P/E 25.2. MNPR currently screens at market cap $431.4M.
Not investment advice. Open the IBM and MNPR stock pages for the full models.
Not investment advice.